Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1551 - 1575 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▲ Formula
Gangliosides LMSP0601DZ01
  • Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262740 1517.845362 C71H127N3O31
Gangliosides LMSP0601ED01
  • NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262772 1517.845362 C71H127N3O31
Gangliosides LMSP0601EF01
  • NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • sialosylparagloboside(d18:1/16:0)
44262788 1517.845362 C71H127N3O31
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AI01
  • Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Leb(d18:1/16:0)
44260676 1518.865763 C72H130N2O31
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AG01
  • Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Ley-6(d18:1/16:0)
44261020 1518.865763 C72H130N2O31
Diacylglycerophosphoinositolglycans LMGP15010193
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(19:2(9Z,12Z)/18:1(9Z))
126457561 1522.768433 C70H123O33P
Diacylglycerophosphoinositolglycans LMGP15010001
  • EtN-P-6ManAlpha1-2ManAlpha1-6ManAlpha1-4GlcNAlpha1-6-PI(14:0/14:0)
  • EtN-P-6Manalpha1-2Manalpha1-6Manalpha1-4GlcNalpha1-6-PI(14:0/14:0)
73242190 1524.699049 C63H118N2O35P2
Diacylglycerophosphoinositolglycans LMGP15010187
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(19:1(9Z)/18:1(9Z))
126457555 1524.784083 C70H125O33P
Diacylglycerophosphoinositolglycans LMGP15010192
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(19:2(9Z,12Z)/18:0)
126457560 1524.784083 C70H125O33P
Diacylglycerophosphoinositolglycans LMGP15010181
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(19:0/18:1(9Z))
126457549 1526.799733 C70H127O33P
Diacylglycerophosphoinositolglycans LMGP15010186
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(19:1(9Z)/18:0)
126457554 1526.799733 C70H127O33P
Pentaacylaminosugars LMSL01050004
  • Rhodobacter sphaeroides Lipid A
171121060 1526.927134 C76H140N2O24P2
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE08
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • SSEA-3 antigen(d18:1/26:1(17Z))
44260203 1526.943618 C76H138N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AP08
  • GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260291 1526.943618 C76H138N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BA08
  • Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260379 1526.943618 C76H138N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BK08
  • Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260459 1526.943618 C76H138N2O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AJ08
  • Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260563 1526.943618 C76H138N2O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AQ08
  • Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260747 1526.943618 C76H138N2O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504BU08
  • Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260971 1526.943618 C76H138N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AC08
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260995 1526.943618 C76H138N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BJ08
  • Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • galgactosyl-paraglobside(d18:1/26:1(17Z))
44261259 1526.943618 C76H138N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BK08
  • Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261267 1526.943618 C76H138N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AN08
  • Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261923 1526.943618 C76H138N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AS08
  • Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • iGb5(d18:1/26:1(17Z))
44261587 1526.943618 C76H138N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AU08
  • Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261603 1526.943618 C76H138N2O28

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024